Trial · NCT07901049
Hugo™ RAS Urology Post-Market Clinical Study
NCT07901049, Not yet recruiting, Medtronic - MITG
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Hugo™ RAS Urology Post-Market Clinical Study. Trials, record NCT07901049. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07901049
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Hugo™ RAS Urology Post-Market Clinical Study
- NCT number
- NCT07901049
- Status
- Not yet recruiting
- Enrollment
- 110 participants, estimated
- Lead sponsor
- Medtronic - MITG
- Conditions
- Prostatectomy, Cystectomy, Nephrectomy, Urologic Cancer
- Interventions
- Robotic Assisted Urologic Surgery
- First posted
- 2026-10-28
- Last updated
- 2026-10-30
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Surgical Success Rate | Intraoperative | Surgical success rate, defined as a Hugo™ RAS procedure free from conversion. A qualifying conversion is an unanticipated switch from a robotic-assisted approach using the Hugo™ RAS System to the use of an alternative robotic-assisted device, laparoscopy, or open surgery. |
| Secondary | Rate of Complications | Enrollment through 30 days follow-up | Rate of subjects with complications meeting Clavien-Dindo Grade ≥ III from first incision through 30 days postprocedure |
| Secondary | Operative Time | Intraoperative | Skin-to-skin operative time |
| Secondary | Hospital Length of Stay | Postoperatively through 30 days follow-up | Total time of hospitalization |
| Secondary | Mortality | Enrollment through 30 day follow-up | 30 Day Mortality Rate |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07901049
GET https://conductscience.org/api/trials/v1/NCT07901049/registered